New Research: Olmesartan Linked to GI Issues

Research conducted by Mayo Clinic investigators has found a link between the prescription drug Olmesartan and severe gastrointestinal issues, according to a Mayo Clinic news release.

Advertisement

 

Olmesartan is a commonly prescribed hypertension/high blood pressure medication. The researchers linked its use to GI issues including nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities, which are common symptoms in patients with celiac disease.

 

“It’s really an awareness issue,” said Mayo Clinic gastroenterologist Joseph Murray, MD, in the release. “We want doctors to be aware of this issue, so if they see a patient who is having this type of syndrome — they think about medications as a possible association. We’ve reported an association. What needs to be known next is the science to understand why there is such an association.”

 

The research is published in the medical journal Mayo Clinic Proceedings.

 

Related Articles on Gastroenterology:

Gastroenterologist Dr. Naga Chalasani Leads Development of Guidelines for Nonalcoholic Fatty Liver Disease

Gastroenterologist Dr. David Pound Discusses Hep C, Risk for Baby Boomers

Study: Six-Food Elimination Diet Improves EoE Symptons

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.